XML 106 R88.htm IDEA: XBRL DOCUMENT v3.3.1.900
SCHEDULE II-CONDENSED FINANCIAL INFORMATION OF REGISTRANT (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 12 Months Ended
Mar. 31, 2013
Dec. 31, 2015
Sep. 30, 2015
Jun. 30, 2015
Mar. 31, 2015
Dec. 31, 2014
Sep. 30, 2014
Jun. 30, 2014
Mar. 31, 2014
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Jun. 30, 2013
ASSETS                                
Fixed maturities (amortized cost, 2015 – $385,281; 2014 – $482,629)                         $ 4,657,561 $ 4,609,614    
Cash and cash equivalents   $ 181,120     $ 197,882 $ 197,882     $ 332,692 $ 197,882 $ 332,692 $ 1,027,625 181,120 197,882 $ 332,692  
Accrued investment income                         40,224 30,518    
Other assets                         91,138 106,390    
Total assets                         5,879,545 5,266,434    
Liabilities:                                
Senior notes                         0 61,918    
Convertible senior notes                         833,503 845,000    
Convertible junior debentures                         389,522 389,522    
Total liabilities                         3,643,405 4,229,531    
Shareholders’ equity:                                
Common stock (one dollar par value, shares authorized 1,000,000; shares issued 2015 - 340,097; 2014 - 340,047; outstanding 2015 - 339,657; 2014 - 338,560)                         340,097 340,047    
Paid-in capital                         1,670,238 1,663,592    
Treasury stock (shares at cost, 2015 – 440; 2014 – 1,487)                         (3,362) (32,937)    
Accumulated other comprehensive loss, net of tax                         (60,880) (81,341)    
Retained earnings (deficit)                         290,047 (852,458)    
Total shareholders' equity                         2,236,140 1,036,903 744,538  
Total liabilities and shareholders' equity                         5,879,545 5,266,434    
Parenthetical information [Abstract]                                
Fixed maturities, amortized cost                         $ 4,684,148 $ 4,602,514    
Common stock, par value (in dollars per share)                         $ 1 $ 1    
Common stock, shares authorized (in shares)                         1,000,000,000 1,000,000,000   680,000,000
Common stock, shares issued (in shares)                         340,097,000 340,047,000    
Common stock, shares outstanding (in shares)                         339,657,000 338,560,000    
Treasury stock, shares at cost (in shares)                         440,000 1,487,000    
Revenues:                                
Investment income, net of expenses   27,926 $ 25,939 $ 25,756 24,120 23,956 $ 22,355 $ 21,180 20,156 103,741 87,647 80,739        
Realized (losses) gains   1,228 640 166 26,327 434 632 522 (231) 28,361 1,357 5,731        
Total revenues                   1,040,781 941,797 1,039,435        
Expenses:                                
Interest expense                   68,932 69,648 79,663        
Total losses and expenses                   553,094 687,074 1,085,587        
Income (loss) before tax                   487,687 254,723 (46,152)        
(Benefit from) provision for income tax   6,584 (695,604) 1,322 3,385 681 249 1,118 726 (684,313) 2,774 3,696        
Net income (loss)   102,418 822,852 113,654 133,076 74,428 72,017 45,522 59,982 1,172,000 251,949 (49,848)        
Other comprehensive income (loss), net of tax                   20,461 36,385 (69,563)        
Comprehensive income (loss)                   1,192,461 288,334 (119,411)        
Cash flows from operating activities:                                
Net income (loss)   102,418 $ 822,852 $ 113,654 133,076 74,428 $ 72,017 $ 45,522 59,982 1,172,000 251,949 (49,848)        
Adjustments to reconcile net income (loss) to net cash used in operating activities:                                
Deferred Federal                   (686,652) 1 7        
Change in certain assets and liabilities:                                
Accrued investment income                   (9,706) 1,142 (4,417)        
Cash flows from investing activities:                                
Purchase of fixed maturities                   (2,462,844) (1,979,917) (3,248,602)        
Sale of fixed maturities                   1,796,153 1,147,624 1,054,985        
Cash flows from financing activities:                                
Net proceeds from convertible senior notes                   0 0 484,625        
Common stock shares issued $ 663,300                 0 0 663,335        
Excess tax benefits related to share-based compensation                   2,117 0 0        
Net decrease in cash and cash equivalents                   (16,762) (134,810) (694,933)        
Cash and cash equivalents at beginning of year         197,882       332,692 197,882 332,692 1,027,625        
Cash and cash equivalents at end of year   181,120       197,882       181,120 197,882 332,692        
Parent Company                                
ASSETS                                
Fixed maturities (amortized cost, 2015 – $385,281; 2014 – $482,629)                         $ 382,565 $ 480,125    
Cash and cash equivalents   19,417     10,507 10,507     20,725 10,507 20,725 175,880 19,417 10,507 $ 20,725  
Investment in subsidiaries, at equity in net assets                         2,903,944 1,821,024    
Accounts receivable - affiliates                         938 312    
Income taxes - current and deferred                         151,318 17,478    
Accrued investment income                         3,700 3,435    
Other assets                         11,325 15,156    
Total assets                         3,473,207 2,348,037    
Liabilities:                                
Senior notes                         0 61,918    
Convertible senior notes                         833,503 845,000    
Convertible junior debentures                         389,522 389,522    
Accrued interest                         14,042 14,694    
Total liabilities                         1,237,067 1,311,134    
Shareholders’ equity:                                
Common stock (one dollar par value, shares authorized 1,000,000; shares issued 2015 - 340,097; 2014 - 340,047; outstanding 2015 - 339,657; 2014 - 338,560)                         340,097 340,047    
Paid-in capital                         1,670,238 1,663,592    
Treasury stock (shares at cost, 2015 – 440; 2014 – 1,487)                         (3,362) (32,937)    
Accumulated other comprehensive loss, net of tax                         (60,880) (81,341)    
Retained earnings (deficit)                         290,047 (852,458)    
Total shareholders' equity                         2,236,140 1,036,903    
Total liabilities and shareholders' equity                         3,473,207 2,348,037    
Parenthetical information [Abstract]                                
Fixed maturities, amortized cost                         $ 385,281 $ 482,629    
Common stock, par value (in dollars per share)                         $ 1 $ 1    
Common stock, shares authorized (in shares)                         1,000,000,000 1,000,000,000    
Common stock, shares issued (in shares)                         340,097,000 340,047,000    
Common stock, shares outstanding (in shares)                         339,657,000 338,560,000    
Treasury stock, shares at cost (in shares)                         440,000 1,487,000    
Revenues:                                
Investment income, net of expenses                   7,586 6,985 5,033        
Realized (losses) gains                   357 395 830        
Total revenues                   7,943 7,380 5,863        
Expenses:                                
Operating expenses and other                   1,089 1,383 511        
Interest expense                   68,932 69,648 79,663        
Total losses and expenses                   70,021 71,031 80,174        
Income (loss) before tax                   (62,078) (63,651) (74,311)        
(Benefit from) provision for income tax                   (125,487) 0 0        
Equity in net income of subsidiaries                   1,108,591 315,600 24,463        
Net income (loss)                   1,172,000 251,949 (49,848)        
Other comprehensive income (loss), net of tax                   20,461 36,385 (69,563)        
Comprehensive income (loss)                   1,192,461 288,334 (119,411)        
Cash flows from operating activities:                                
Net income (loss)                   1,172,000 251,949 (49,848)        
Adjustments to reconcile net income (loss) to net cash used in operating activities:                                
Equity in net income of subsidiaries                   (1,108,591) (315,600) (24,463)        
Dividends received from subsidiaries                   6,500 0 0        
Deferred Federal                   (125,532) 0 0        
Other                   22,849 14,862 21,693        
Change in certain assets and liabilities:                                
Accounts receivable - affiliates                   (626) 68 289        
Income taxes receivable                   (8,308) 480 (3)        
Accrued investment income                   (265) 194 (2,611)        
Accrued interest                   (652) (188) (15,577)        
Net cash used in operating activities                   (42,625) (48,235) (70,520)        
Cash flows from investing activities:                                
Capital distributions from (contributions to) subsidiaries                   32,000 0 (800,000)        
Purchase of fixed maturities                   (295,010) (553,538) (563,968)        
Sale of fixed maturities                   386,385 613,322 148,608        
Net cash provided by (used in) investing activities                   123,375 59,784 (1,215,360)        
Cash flows from financing activities:                                
Net proceeds from convertible senior notes                   0 0 484,625        
Common stock shares issued                   0 0 663,335        
Repayment of long-term debt                   (73,957) (21,767) (17,235)        
Excess tax benefits related to share-based compensation                   2,117 0 0        
Net cash (used in) provided by financing activities                   (71,840) (21,767) 1,130,725        
Net decrease in cash and cash equivalents                   8,910 (10,218) (155,155)        
Cash and cash equivalents at beginning of year         $ 10,507       $ 20,725 10,507 20,725 175,880        
Cash and cash equivalents at end of year   $ 19,417       $ 10,507       $ 19,417 $ 10,507 $ 20,725